about
A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran.Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran.Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors.Levels of interleukin-(IL)-12p40 are markedly increased in Brucellosis among patients with specific IL-12B genotypes.Association between Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Pulmonary Tuberculosis.TIRAP rs8177374 gene polymorphism increased the risk of pulmonary tuberculosis in Zahedan, southeast Iran.CD209 promoter -336 A/G (rs4804803) polymorphism is associated with susceptibility to pulmonary tuberculosis in Zahedan, southeast Iran.Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism.TNF-α -238, -308, -863 polymorphisms, and brucellosis infection.Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.HLA-G gene 14-bp deletion variant protects Iranian subjects against chronic hepatitis B infection.Association of PTPN22 rs2476601 and EGFR rs17337023 Gene polymorphisms and rheumatoid arthritis in Zahedan, Southeast Iran.Relationship between γ-interferon gene polymorphisms and susceptibility to brucellosis infection.Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population.50-bp Ins/Del polymorphism of SOD1 is associated with increased risk of cardiovascular disease.Investigation of FGF1 and FGFR gene polymorphisms in a group of Iranian patients with nonsyndromic cleft lip with or without cleft palate.Association between the apelin rs2235306 gene polymorphism and metabolic syndrome.Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.Association between NPHS1 and NPHS2 gene variants and nephrotic syndrome in children.Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report.Investigation of CTLA-4 and CD86 gene polymorphisms in Iranian patients with brucellosis infectionAssociation of IRGM polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast IranAssociation of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndromeAssociation between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian populationAssociation between the rs7700944 polymorphism in the TIM-4 gene and rheumatoid arthritis in Zahedan, southeast IranAssociation between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancerhsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population
P50
Q34475865-C017EFB9-4230-4418-812A-A0E8C3CD6BE4Q34551169-A3B45DA0-887B-40F4-B706-91312DDE32A6Q35133898-BA6E66BA-9773-4759-ACC4-F49429BD7E8BQ38995162-123E6A72-0D9D-43E3-BA64-16DA57881C6BQ38995166-D32D8BF2-04C2-4645-B303-4A7C11D7F6E8Q39052362-72C95B3E-B585-4F2F-B3E6-272D9C1332F7Q39289321-8C0FE414-E513-47BC-93E7-6B938EE62F97Q39289328-471E677E-300B-4EE3-87D8-EF3C9D38867FQ40399586-1BBA82B2-13A2-412E-953B-D2F88AB588AEQ40903505-CB08868A-D70B-4B84-AF0D-2AD54295136EQ40908682-108293DE-8091-4D1D-9653-38AF05C81870Q41996199-992665E2-F684-4123-B297-03EB221E8E90Q43654959-F31C2FEF-629D-41D3-B070-C859B472C129Q43712703-57E6A235-2F6E-4286-AFAD-97802226DCDFQ46156792-770F3C04-B550-400F-AC67-56325E05DC7EQ46848647-AC7359C7-1AB0-4A2B-A522-1A9144A0B3DCQ50681031-0538205B-D945-42D6-AA07-216F61CEF978Q51310503-31498798-14C1-40CF-8108-E724B6E9FA32Q51334749-80F42020-7BB8-4C14-80E5-8E1353E365D3Q54177026-49D9B84A-E983-4EF4-B2AF-8F347CA2655FQ54292021-DB249A1F-EA0C-4672-968B-B6446345AF74Q56897071-85E3A2AA-8822-45AA-9FA9-8386E4045876Q58915151-D0FED0A4-9479-4E29-AEA9-DEDB90566234Q85397127-DDC8C142-0636-4B7A-B157-7A49F6F45B8CQ85642139-405DB44E-B037-4937-AA6C-4140384A342EQ86704417-2907C792-8D2D-4CE9-A3E9-B422AF470C46Q86758785-428C341A-A0CD-4297-8C5B-FEF44EFDD1B4Q87278794-3EFBECC9-5B46-40A2-BB96-2A9EDEE496D3
P50
description
investigador
@es
researcher
@en
name
Ebrahim Eskandari-Nasab
@en
type
label
Ebrahim Eskandari-Nasab
@en
prefLabel
Ebrahim Eskandari-Nasab
@en
P31
P496
0000-0001-7789-4194